J.G. Chemicals FY26 Revenue Rises 14.7% to INR 9,729 Mn; Posts Record PAT

J.G. Chemicals has announced its audited financial results for the quarter and year ended March 31, 2026, approved at the Board of Directors meeting held on May 14, 2026. The company reported a strong performance in Q4 FY26 with consolidated revenue from operations growing 27.6% year-on-year to INR 2,861.69 Mn. Consolidated net profit for the quarter increased by 18.9% to INR 189.00 Mn, compared to INR 159.06 Mn in the same period last year. Q4 consolidated EBITDA stood at INR 214 Mn versus INR 196 Mn in the year-ago period, while the EBITDA margin contracted to 7.48% from 8.74% year-on-year. The board recommended a final dividend of 11% at ₹1.10 per equity share of ₹10 each for FY26, subject to shareholder approval at the ensuing 25th Annual General Meeting.

Consolidated Financial Performance

For the full fiscal year FY26, the company achieved its highest-ever annual revenue, EBITDA, and PAT on a consolidated basis. Consolidated revenue from operations stood at INR 9,729.30 Mn, a 14.7% increase from INR 8,479.44 Mn in the previous year. Consolidated profit after tax (PAT) for FY26 rose by 2.8% to INR 686.49 Mn from INR 667.59 Mn. The consolidated basic and diluted earnings per share for FY26 stood at ₹16.81, compared to ₹16.34 in the prior year. Net profit attributable to owners of the parent for FY26 was INR 658.78 Mn, while non-controlling interest accounted for INR 27.71 Mn.

Metric: Q4 FY26 Q4 FY25 YoY Growth Revenue from Operations (₹ Mn): 2,861.69 2,242.54 27.6% EBITDA (₹ Mn): 214 196 — EBITDA Margin (%): 7.48% 8.74% — Net Profit (₹ Mn): 189.00 159.06 18.9% Profit Before Tax (₹ Mn): 254.09 215.52 17.9% Basic EPS (₹)*: 4.61 3.92 —

Metric: FY26 FY25 YoY Growth Revenue from Operations (₹ Mn): 9,729.30 8,479.44 14.7% Net Profit (₹ Mn): 686.49 667.59 2.8% Profit Before Tax (₹ Mn): 921.14 899.00 2.5% Basic EPS (₹): 16.81 16.34 —

*Not annualised

Consolidated Balance Sheet Highlights

On a consolidated basis, total assets stood at INR 5,692.50 Mn as at March 31, 2026, compared to INR 4,979.30 Mn in the prior year. Total equity attributable to equity holders of the company was INR 5,284.18 Mn, with non-controlling interest at INR 126.36 Mn, bringing total equity to INR 5,410.55 Mn. Property, Plant and Equipment on a consolidated basis increased significantly to INR 672.23 Mn from INR 389.06 Mn, reflecting ongoing capital expenditure. Consolidated cash and cash equivalents at the end of the year stood at INR 162.17 Mn, compared to INR 313.77 Mn at the beginning of the year.

Metric: 31.03.2026 (₹ Mn) 31.03.2025 (₹ Mn) Total Assets: 5,692.50 4,979.30 Total Equity: 5,410.55 4,746.13 Property, Plant & Equipment: 672.23 389.06 Cash & Cash Equivalents: 162.17 313.77 Current Borrowings: 64.48 1.51

Standalone Financial Performance

On a standalone basis, J.G. Chemicals reported revenue from operations of INR 879.21 Mn for Q4 FY26, compared to INR 755.04 Mn in Q4 FY25. Standalone net profit after tax for the quarter stood at INR 71.86 Mn, up from INR 63.60 Mn in the year-ago period. For the full year FY26, standalone revenue from operations was INR 2,889.48 Mn versus INR 2,718.20 Mn, while standalone PAT rose to INR 214.50 Mn from INR 200.19 Mn. Standalone basic and diluted EPS for FY26 stood at ₹5.47, compared to ₹5.11 in FY25. Total standalone assets were INR 3,457.39 Mn as at March 31, 2026, versus INR 3,218.15 Mn in the prior year.

Metric: FY26 (₹ Mn) FY25 (₹ Mn) Revenue from Operations: 2,889.48 2,718.20 Net Profit After Tax: 214.50 200.19 Profit Before Tax: 287.11 270.00 Basic EPS (₹): 5.47 5.11 Total Assets: 3,457.39 3,218.15 Total Equity: 3,311.36 3,119.51

IPO Proceeds Utilisation

The company received ₹1,650 million as proceeds from the fresh issue of equity shares. As at March 31, 2026, ₹1,161.92 million had been utilised, with ₹331.32 million remaining un-utilised and invested in term deposits with a scheduled bank. The board approved a variation in the timeline for utilisation of IPO proceeds towards the R&D Centre, with ₹42.62 million still unspent as at March 31, 2026, to be deployed in FY27 due to delays in construction works and equipment procurement. The objects of the issue remain unchanged, and the company has already utilised ₹131.466 crores in accordance with the report of ICRA Limited, the Monitoring Agency.

Object of Issue: Proposed (₹ Mn) Utilised (₹ Mn) Un-utilised (₹ Mn) Repayment of subsidiary borrowings: 250.00 250.00 — R&D Centre capex (subsidiary): 60.58 17.96 42.62 Long-term working capital (subsidiary): 600.00 431.40 168.60 Long-term working capital (company): 350.00 229.90 120.10 General corporate purposes: 232.66 232.66 — Total: 1,493.24 1,161.92 331.32

Corporate Governance & Auditor Appointments

At the board meeting, the company approved the re-appointment of M/s Debabrota Banerjee & Associates as Cost Auditor, SS Kothari Mehta & Co. LLP as Internal Auditor, and M/s. S Jaykishan, Chartered Accountants, as Tax Auditor for FY 2026-2027, all effective from April 01, 2026. The statutory auditors issued an unmodified audit opinion on both standalone and consolidated financial statements for the quarter and year ended March 31, 2026. The company confirmed it does not qualify as a Large Corporate under the applicable SEBI circular, with outstanding borrowings of ₹6.15 crore as on March 31, 2026, a long-term credit rating of CRISIL A/Stable, and a short-term rating of CRISIL A1.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.